Targeted toxicological testing to investigate the role of endocrine disrupters in puberty disorders

Francesca Maranghi1, Alberto Mantovani

  • 1Food and Veterinary Toxicology Unit, Dept. Food Safety and Veterinary Public Health, Istituto Superiore di Sanità, Viale Regina Elena, 299 00161 Rome, Italy. francesca.maranghi@iss.it

Insights

The endocrine system regulates puberty, but its onset is not fully understood. Exposure to endocrine disruptors can impact reproductive development, necessitating further research and risk assessment for vulnerable populations.

Area of Science:

  • Endocrinology
  • Toxicology
  • Reproductive Biology

Background:

  • Puberty onset is regulated by the endocrine system, with its precise physiological triggers remaining unclear.
  • Disruptions to the endocrine system during development can significantly impair reproductive function.
  • Altered puberty can result from general toxicity or specific chemical exposures, particularly endocrine disruptors.

Purpose of the Study:

  • To highlight the potential impact of endocrine disruptors on puberty development.
  • To address the need for data on the effects of chemicals on immature organisms for risk assessment.
  • To emphasize the importance of integrating human medicine and experimental toxicology for a comprehensive analysis.

Main Methods:

  • Review of toxicological studies on puberty development.
  • Analysis of endocrine disrupter (ED) effects, including anti-estrogenic and anti-androgenic activities.
  • Examination of interactions with the hypothalamic-pituitary-gonadal (HPG) axis.

Main Results:

  • Exposure to endocrine disruptors with (anti)estrogenic or (anti)androgenic activity is biologically plausible to affect puberty.
  • Existing toxicological data suggest specific chemicals can interfere with puberty development.
  • Risk assessment agencies require data on children's vulnerability to chemical exposures.

Conclusions:

  • Further research is needed to understand the mechanisms of puberty onset and disruption.
  • Developing robust tools for assessing chemical hazards in immature organisms is crucial.
  • An interdisciplinary approach integrating human medicine and experimental toxicology is essential for sound risk analysis of endocrine disruptors.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...